Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Paganetti

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Neurology International|May 26, 2026
Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic ApproachAlfonso Martinisi, Paolo Paganetti
Frontiers in Cell and Developmental Biology|January 25, 2021
Hijacking Endocytosis and Autophagy in Extracellular Vesicle Communication: Where the Inside Meets the OutsideGiona Pedrioli, Paolo Paganetti
Brain Sciences|November 19, 2020
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in CancerStéphanie Papin, Paolo Paganetti
Molecular Biology of the Cell|July 18, 2008
Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACEOmar Vanoni, Paolo Paganetti, Maurizio Molinari
Molecular Neurodegeneration|February 11, 2009
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunctionAndreas Weiss, Ana Roscic, Paolo Paganetti
Frontiers in Neurology|December 7, 2020
Chloroquine, the Coronavirus Crisis, and Neurodegeneration: A PerspectiveGiona Pedrioli, Rickie Patani, Paolo Paganetti
Journal of Neurochemistry|April 16, 2002
The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activityFrauke Fischer, Maurizio Molinari, Ursula Bodendorf, et al.
Neuro-Degenerative Diseases|June 29, 2007
BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic miceMartin C Herzig, Paolo Paganetti, Matthias Staufenbiel, et al.
Plos One|June 17, 2011
Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's diseaseAnna Bobrowska, Paolo Paganetti, Patrick Matthias, et al.
The Journal of Cell Biology|March 16, 2005
beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptidePaolo Paganetti, Verena Calanca, Carmela Galli, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Neurology International|May 26, 2026
Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic ApproachAlfonso Martinisi, Paolo Paganetti
Frontiers in Cell and Developmental Biology|January 25, 2021
Hijacking Endocytosis and Autophagy in Extracellular Vesicle Communication: Where the Inside Meets the OutsideGiona Pedrioli, Paolo Paganetti
Brain Sciences|November 19, 2020
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in CancerStéphanie Papin, Paolo Paganetti
Molecular Biology of the Cell|July 18, 2008
Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACEOmar Vanoni, Paolo Paganetti, Maurizio Molinari
Molecular Neurodegeneration|February 11, 2009
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunctionAndreas Weiss, Ana Roscic, Paolo Paganetti
Frontiers in Neurology|December 7, 2020
Chloroquine, the Coronavirus Crisis, and Neurodegeneration: A PerspectiveGiona Pedrioli, Rickie Patani, Paolo Paganetti
Journal of Neurochemistry|April 16, 2002
The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activityFrauke Fischer, Maurizio Molinari, Ursula Bodendorf, et al.
Neuro-Degenerative Diseases|June 29, 2007
BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic miceMartin C Herzig, Paolo Paganetti, Matthias Staufenbiel, et al.
Plos One|June 17, 2011
Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's diseaseAnna Bobrowska, Paolo Paganetti, Patrick Matthias, et al.
The Journal of Cell Biology|March 16, 2005
beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptidePaolo Paganetti, Verena Calanca, Carmela Galli, et al.
Pageof 8